• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Pathology

Tempus Launches Pathology-Driven AI Platform

by Jasmine Pennic 03/21/2022 Leave a Comment

Tempus Launches Pathology-Driven AI Platform

What You Should Know: - Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. - With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

by HIMSS22 Summary 03/16/2022 Leave a Comment

HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions,

Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More

Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses

by Fred Pennic 03/16/2022 Leave a Comment

Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses

What You Should Know: - Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency. - Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health. Partnership Goals The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More

Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology

by Jasmine Pennic 03/16/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers. - Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More

Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology

by Jasmine Pennic 03/09/2022 Leave a Comment

Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology

What You Should Know: - Proscia, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale. - The cooperation agreement increases the availability of the companies' best-of-breed, unified solution that combines Proscia's Concentriq® platform and Hamamatsu's NanoZoomer® series of whole slide scanners to deliver
Read More

Why Digital Pathology Platform Adoption Will Fail Without Interoperability

by Coleman Stavish, CTO, Proscia 12/23/2021 Leave a Comment

Why Digital Pathology Platform Adoption Will Fail Without Intoperability

The global pandemic has cast a spotlight on the impact of digital transformation in healthcare. From ensuring access to care with telemedicine to accelerating vaccine development, technology has rapidly unlocked new sources of value for patients, providers, and researchers alike. While much of this has played out before our very eyes, other advancements have been less visible but equally as significant. Consider the rise of digital pathology. Pathology sits at the core of disease diagnosis;
Read More

PathologyWatch Lands $25M for Digital Dermpath Lab Platform

by Jasmine Pennic 11/16/2021 Leave a Comment

PathologyWatch Lands $25M for Digital Dermpath Lab Platform

What You Should Know:  - Digital lab and pathology platform PathologyWatch, today announced $25 million in Series B funding with participation from Ceros Capital Markets, Rock Creek Capital,Springtide Capital, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group, and existing investors. - AI in diagnostic services grew by 80% in 2020, largely in response to the COVID-19 pandemic, which also brought to our attention the need for more equitable and accessible healthcare. With
Read More

HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps

by Fred Pennic 10/18/2021 Leave a Comment

HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps

What You Should Know:  - Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology,
Read More

Philips, Ibex Medical Analytics Partner on AI-Powered Digital Pathology Adoption

by Fred Pennic 04/08/2021 Leave a Comment

Philips, Ibex Medical Analytics Partner on AI-Powered Digital Pathology Adoption

What You Should Know: - Philips and Ibex Medical Analytics announced a strategic partnership to globally commercialize clinically proven, AI-powered digital pathology solutions. The collaboration further cements Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis. - The trend towards centralized pathology labs, the global shortage of trained pathologists, and increasing demands on histopathology posed by the growing number of cancer
Read More

Proscia Secures $23M for AI-Enabled Digital Pathology Solutions

by Fred Pennic 12/01/2020 Leave a Comment

Proscia Secures $23M for AI-Enabled Digital Pathology Solutions

What You Should Know: - Proscia secures $23M in Series B funding led by Scale Venture Partners for its AI-enabled digital pathology solutions. - Proscia will use the funding to expand its AI application portfolio, boost commercial expansion, and advance its regulatory strategy to secure FDA approval. Proscia, a Philadelphia-based provider of digital and computational pathology solutions, today announced it has secured $23M in Series B funding  led by Scale Venture
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |